{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:27:06Z","timestamp":1794245226159,"version":"4.9.0"},"reference-count":75,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2021,8,3]]},"DOI":"10.1080\/17474086.2021.1962278","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T10:21:31Z","timestamp":1628158891000},"page":"741-750","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["New approaches to managing relapsed\/refractory Hodgkin lymphoma: the role of checkpoint inhibitors and beyond"],"prefix":"10.1080","volume":"14","author":[{"given":"Jessica","family":"Caro","sequence":"first","affiliation":[{"name":"Perlmutter Cancer Center at NYU Langone Health","place":["New York, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Diefenbach","sequence":"additional","affiliation":[{"name":"Perlmutter Cancer Center at NYU Langone Health","place":["New York, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"key":"e_1_3_4_3_1","unstructured":"Cancer stat facts: Hodgkin lymphoma. 2021 cited 2021 Apr 26; Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/hodg.html."},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.07.005"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO;2-7"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199211193272102"},{"key":"e_1_3_4_7_1","first-page":"CD007941","article-title":"Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma","author":"Bauer K","year":"2011","unstructured":"Bauer K, Skoetz N, Monsef I, et al. Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma. Cochrane Database Syst Rev. 2011;8:CD007941.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510093"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000719"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1111961"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg703"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.02.022"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07645.x"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-016-2619-9"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704214"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.0410"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2004.n.017"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2542"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.2711"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.8401"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-282780"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.26.021607.090331"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1514296"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-085159"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192461099"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200690"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0310"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0810958105"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131916"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2608"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9076"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv615"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.4482"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0855"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2326"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0201"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411087"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.583.583"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.0793"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001367"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.3467"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.72.1316"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000324"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00005-X"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2437_54"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000239"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504030"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910231"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.183.183"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30221-0"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1339"},{"key":"e_1_3_4_52_1","unstructured":"Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin lymphoma. [cited 2021 May 24]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01896999."},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-10-811224"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-123162"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-123879"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000401"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-130539"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01056"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.9789"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00315"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007400"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30275-1"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60165-9"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000215"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.08.028"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0167"},{"key":"e_1_3_4_67_1","first-page":"106","article-title":"Increased response rates to salvage chemotherapy administered after PD-1\/PD-L1 inhibitors in patients with non-small cell lung cancer","volume":"13","author":"Park SE","year":"2018","unstructured":"Park SE, Lee SH, Ahn JS, et al. Increased response rates to salvage chemotherapy administered after PD-1\/PD-L1 inhibitors in patients with non-small cell lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2018;13:106\u2013111.","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.9084"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V130.Suppl_1.650.650"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-614636"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004701"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI94306"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-111202"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01342"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-113534"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0850"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.5304"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2021.1962278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T10:17:09Z","timestamp":1742379429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2021.1962278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":75,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,3]]}},"alternative-id":["10.1080\/17474086.2021.1962278"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2021.1962278","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-06-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}